SARDOCOR Trademark

Trademark Overview


On Tuesday, February 11, 2025, a trademark application was filed for SARDOCOR with the United States Patent and Trademark Office. The USPTO has given the SARDOCOR trademark a serial number of 99036195. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 11, 2025. This trademark is owned by Sardocor Corp.. The SARDOCOR trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Adhesive plasters for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular agents for medical purposes; cardiovascular medicines; cells for medical or clinical use; cells for medical purposes; chemical reagents for medical or veterinary purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; diagnostic preparations for medical purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; dietary supplements for humans; dietary supplements for pets in the form of treats; dietetic foods adapted for medical purposes; disinfectants; food for babies; fungicides; gene therapy products, namely, genetically engineered tissues for transplant purposes; herbicides; medicinal preparations for regenerative and reparative therapies; nucleic acid seq...

Blood bank services; healthcare services; human tissue bank services; medical care services; medical services; medical testing and evaluation; organ and tissue bank services; stem cell therapy services; medical services and consultancy services relating to cardiovascular diseases

Bacteriological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biomedical research services for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biotechnology research for use in gene and cell therapies for cardiovascular diseases and systemic diseases associated with cardiac pathology; chemical research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting clinical trials; conducting clinical trials for others; conducting early evaluations in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic...
sardocor

General Information


Serial Number99036195
Word MarkSARDOCOR
Filing DateTuesday, February 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAdhesive plasters for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular agents for medical purposes; cardiovascular medicines; cells for medical or clinical use; cells for medical purposes; chemical reagents for medical or veterinary purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; diagnostic preparations for medical purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; dietary supplements for humans; dietary supplements for pets in the form of treats; dietetic foods adapted for medical purposes; disinfectants; food for babies; fungicides; gene therapy products, namely, genetically engineered tissues for transplant purposes; herbicides; medicinal preparations for regenerative and reparative therapies; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; preparations for destroying vermin; sanitary preparations for medical use; sanitary preparations for veterinary use; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprised of living tissues; synthetic peptides for pharmaceutical purposes; synthetic peptides for the treatment of respiratory conditions; veterinary preparations for regenerative and reparative therapies; pharmaceutical preparations for the treatment of heart disorders and systemic diseases associated with cardiac pathology; drugs for the prevention and treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; living cells for medical purpose
Goods and ServicesBlood bank services; healthcare services; human tissue bank services; medical care services; medical services; medical testing and evaluation; organ and tissue bank services; stem cell therapy services; medical services and consultancy services relating to cardiovascular diseases
Goods and ServicesBacteriological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biomedical research services for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biotechnology research for use in gene and cell therapies for cardiovascular diseases and systemic diseases associated with cardiac pathology; chemical research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting clinical trials; conducting clinical trials for others; conducting early evaluations in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; development of biopharmaceutical products and medicine for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; drug discovery services; engineering services, particularly technical project planning and design engineering of lines for the processing of web products; industrial research in the field of regenerative and reparative therapies; medical and pharmaceutical research services in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical laboratory services; pharmaceutical research services; pharmaceutical drug development services for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; product evaluation and analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development and consultation related thereto in the field of technique; research and development of new products for others; research and development of vaccines and medicines for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; scientific research in the field of gene therapy; stem cell research services; technical research in the field of pharmaceutical studies; technology research in the field of regenerative and therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2025
Primary Code042
First Use Anywhere DateThursday, May 6, 2021
First Use In Commerce DateThursday, September 23, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2025
Primary Code044
First Use Anywhere DateThursday, May 6, 2021
First Use In Commerce DateThursday, September 23, 2021

Trademark Owner History


Party NameSardocor Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, February 11, 2025NEW APPLICATION ENTERED
Tuesday, February 11, 2025APPLICATION FILING RECEIPT MAILED